Related Experiment Video
Updated: Apr 28, 2026

05:50
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
2.1K
Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering
Daniel Moser1, Joanna M Wisniewska1, Steffen Hahn1
1Institute of Pharmaceutical Chemistry, Johann Wolfgang Goethe University , Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany.
ACS Medicinal Chemistry Letters
|June 6, 2014
Summary
Researchers discovered novel dual 5-lipoxygenase/soluble epoxide hydrolase inhibitors using an in silico approach. This study identified nine new compounds, including a promising dual-target inhibitor, through virtual screening and in vitro validation.
Area of Science:
- Medicinal Chemistry
- Computational Drug Discovery
Background:
- Dual-target inhibitors are gaining prominence in drug discovery.
- Targeting both 5-lipoxygenase (5-LO) and soluble epoxide hydrolase (sEH) offers therapeutic potential.
Purpose of the Study:
- To discover novel dual inhibitors of 5-lipoxygenase and soluble epoxide hydrolase.
- To employ an advanced in silico methodology for identifying potential drug candidates.
Main Methods:
- Utilized a ligand-based virtual screening approach.
- Incorporated extensive pharmacophore elucidation and alignment.
- Applied shape-based scoring for virtual screening.
- Performed in vitro validation of identified compounds.
Main Results:
- Successfully identified nine novel inhibitors.
- One compound demonstrated dual inhibitory activity against 5-LO and sEH.
- The in silico approach proved effective in discovering new chemical entities.
Conclusions:
- The study successfully identified novel dual 5-LO/sEH inhibitors.
- The employed computational methods are effective for discovering multi-target inhibitors.
- These findings provide a foundation for further development of dual-target therapeutics.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
10.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.3K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K

